Genpact Limited (G) Tops Q2 EPS by 7c

Genpact Limited (NYSE: G) reported Q2 EPS of $0.43, $0.07 better than the analyst estimate of $0.36. Revenue for the quarter came in at $670.7 million versus the consensus estimate of $647.46 million.

For earnings history and earnings-related data on Genpact Limited (G) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Alnylam Pharmaceuticals (ALNY) PT Lowered to $410 at BofA Securities
• BofA Securities Starts Bel Fuse (BELFB) at Buy